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Notch receptors are transmembrane proteins that
undergo activating proteolysis in response to ligand
stimulation. A negative regulatory region (NRR)main-
tains receptor quiescence by preventing protease
cleavage prior to ligand binding. We report here the
X-ray structure of the NRR of autoinhibited human
Notch3, and compare it with the Notch1 and Notch2
NRRs. The overall architecture of the autoinhibited
conformation, in which three LIN12-Notch repeat
(LNR) modules wrap around a heterodimerization
domain, is preserved in Notch3, but the autoinhibited
conformation of the Notch3 NRR is less stable. The
Notch3 NRR uses a highly conserved surface on
the third LNR module to form a dimer in the crystal.
Similar homotypic interfaces exist in Notch1 and
Notch2. Together, these studies reveal distinguish-
ing structural features associated with increased
basal activity of Notch3, demonstrate increased
ligand-independent signaling for disease-associated
mutations that map to the Notch3 NRR, and identify a
conserved dimerization interface present in multiple
Notch receptors.
INTRODUCTION
The Notch signaling pathway influences numerous cell fate
decisions during development and maintains tissue homeosta-
sis in adults. Mammals have four Notch receptors and five
canonical ligands, three homologous to Drosophila Delta
(DLL1, DLL3, and DLL4), and two homologous to Drosophila
Serrate (Jag1, Jag2). Whereas mammalian Notch1 and Notch2
are expressed in a wide variety of tissues and are essential for
mammalian development, Notch3 expression is largely
restricted to vascular smoothmuscle. Thus,mice lacking Notch3
exhibit developmental defects limited primarily to vascular
smooth muscle maturation and arterial specification (DomengaStructure 23, 1et al., 2004). Aberrant Notch3 expression has also been linked
to a variety of different disease states, including the hereditary
stroke syndrome CADASIL and ovarian cancer (Cancer Genome
Atlas Research Network, 2011; Joutel et al., 1996; Park et al.,
2006).
Normally, Notch receptors transmit signals by undergoing
regulated proteolysis in response to transmembrane ligands pre-
sented on the surface of adjacent cells. The intrinsic resistance
of Notch receptors to activating proteolysis is dependent on
the integrity of a negative regulatory region (NRR), which encom-
passes a series of three LIN12-Notch repeats (LNRs) and a jux-
tamembrane heterodimerization domain (HD). The HD is cleaved
during normal receptor maturation by a furin-like protease at a
site called S1 (Logeat et al., 1998), but the NRR is resistant to
further proteolysis in the absence of ligand (Gordon et al.,
2007; Sanchez-Irizarry et al., 2004). Ligand stimulation induces
receptor sensitivity to metalloprotease cleavage at a site called
S2 (Brou et al., 2000; Groot et al., 2014; Mumm et al., 2000),
which lies near the C-terminal end of the HD (Figure 1A). After
metalloprotease cleavage, the truncated receptor, called
NEXT, is primed for intramembrane cleavage at site S3 and addi-
tional sites by gamma-secretase, which releases the intracellular
part of Notch (NICD) from the membrane. NICD migrates to the
nucleus, where it assembles a transcriptional activation complex
that turns on the expression of Notch-responsive genes (Kopan
and Ilagan, 2009).
The X-ray structures of the Notch1 and Notch2 NRRs show
that autoinhibition results from the masking of the metallopro-
tease cleavage site in the HD by the first two LNR modules
and the linker between them (Gordon et al., 2009, 2007). More-
over, mutations of the Notch1 NRR that are found in nearly half
of human T-cell acute lymphoblastic leukemia/lymphomas lead
to increased ligand-independent signaling (Weng et al., 2004),
highlighting the importance of the NRR in stabilizing the quies-
cent, ‘‘off’’ state of the receptor.
Here, we report the structure of the Notch3 NRR in its autoin-
hibited conformation. The structure reveals differences in pack-
ing interactions among the three NRRs that may account for
the increased basal proteolytic sensitivity of Notch3. We also
observe an increase in ligand-independent signaling associated
with various point mutations that have been identified in different227–1235, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1227
Figure 1. Structure of the Notch3 NRR and
Comparison with NRRs from Other Notch
Receptors
(A) Top: Domain organization of the Notch3 NRR.
Bottom: Ribbon representation of the X-ray
structure of the Notch3 NRR. The three LNR
modules are colored in different shades of pink as
in the schematic, and the HD domain is shaded
cyan up to the furin cleavage site, and in darker
blue C-terminal to the furin site. The three calcium
ions are in green, disulfide bonds in yellow, and the
sugar residues at the glycosylation site on the HD
domain have a yellow carbon backbone with
heteroatoms in CPK colors. The zoomed-in views
shown in (B) and (C) are boxed in red.
(B–D) Comparison among Notch1 (gray; PDB:
3ETO), Notch2 (gold; PDB: 2OO4), and Notch3
(multicolored) NRRs. (B) Zoomed-in view of the
LNR-A interface with LNR-B, highlighting the
divergence of Notch3 at P1408, and its impact on
the conserved cluster of tryptophan residues. The
sugars have been removed for clarity. (C) View
focusing on the interface between the LNR-C
module and the HD domain, illustrating the
different packing arrangement in Notch3
compared to Notch1 and Notch2. (D) Close-up
view of the N-acetylglucosamine residue attached
to N1438 interacting with residues at the C-ter-
minal end of helix 3 of the HD domain. See also
Figure S1.disease states, and identify a dimerization interface conserved
among the Notch1, Notch2, and Notch3 receptors.
RESULTS
Structure Overview and Unique Features of the
Notch3 NRR
The structure of the Notch3 NRRwas solved to 2.4 A˚ resolution by
X-ray crystallography, using the Notch1 NRR (PDB: 3ETO) as a
search model for molecular replacement (Table 1; see Experi-
mentalProcedures).TheNotch3NRRadoptsacompact structure,
with the three LNRmodulesenveloping theHDdomain in a closed,
autoinhibited conformation (Figure 1A). The domain architecture is
similar to the arrangement seen in the structures of the human
Notch1 and Notch2 NRRs (Gordon et al., 2009, 2007; Wu et al.,
2010), and confirms that the structural basis for Notch3 autoinhibi-
tion results from the packing of the LNRs against the HD domain,
precluding access of metalloprotease to the S2 cleavage site.
Detailed comparison of the Notch3 NRR with the Notch1 and
Notch2 NRRs reveals substantial differences among the
structures at the interdomain interfaces (Figures 1B and 1C).
The backbone root-mean-square differences (RMSDs) for
superposition of the Notch3 NRR on that of Notch1 or Notch2
are 2.25 and 2.29 A˚, respectively, compared with a 1.65 A˚
RMSD for the Notch1/Notch2 NRR superposition (Figure S1).1228 Structure 23, 1227–1235, July 7, 2015 ª2015 Elsevier Ltd All rights reservedOne important distinguishing feature of
the Notch3 structure occurs at the
interface between LNR-A and LNR-B
(Figure 1B). Three absolutely conserved
tryptophan residues (W1412, W1425,and W1434 in Notch3) play a critical role in stabilizing this
interface. In Notch1 and Notch2, this aromatic cluster is further
reinforced by an LNR-A histidine residue (H1471 in Notch1 and
H1446 in Notch2), which engages the third tryptophan of the
cluster in an aromaticp-stacking interaction. In Notch3, a proline
residue (P1408) substitutes for histidine and makes only limited
van derWaals contact withW1434, suggesting that this interface
is less stable in the Notch3 NRR.
Another difference that distinguishes the Notch3NRR is the na-
ture of the interface between LNR-Cand the first helix of theN-ter-
minalpartof theHDdomain (HD-N) (Figure1C). InbothNotch1and
Notch2, there isa salt bridge formedbetweenanaspartate inLNR-
C and an arginine from the external face of the helix (D1534 to
R1595 in Notch1, and D1506 to R1567 in Notch2). This linkage
defines the interdomain orientation of the twomodules and estab-
lishes the distance of closest approach between the helix and
LNR-C. InNotch3, the analogous interaction becomesa hydrogen
bond between a glutamate (E1472) on LNR-C and a glutamine
(Q1533) on the helix. The shorter glutamine side chain at that posi-
tion allows the helix to pack more tightly against LNR-C. This
close-packed arrangement is further stabilized by an additional
interaction between the same E1472 residue of LNR-C and
R1534, an arginine residue at the next position of the helix.
An additional striking feature of the NRR from Notch3 is the
position of the N-linked sugars attached to N1438 of LNR-B
Table 1. X-Ray Data Collection and Refinement Statistics
Notch3 NRR
X-Ray Data Collection
X-Ray source 24-ID-E (NECAT)
Wavelength (A˚) 0.9792
Resolution (A˚) 49.18–2.48 (2.57–2.48)b
Space group C 2
Cell dimensions
a, b, c (A˚) 122.5, 64.3, 83.1
a, b, g () 90.0, 105.2, 90.0
Rmerge
a (%) 13.2 (78.6)
CC1/2 99.2 (68.2)
I/s (I) 13.27 (2.23)




Unique reflections 22,317 (2,231)
Subunits/asymmetric unit 2
Rwork/Rfree 0.1829/0.2069 (0.2595/0.3157)










Bond lengths (A˚) 0.004














bNumbers in parentheses refer to the highest-resolution shell.(Figure 1D). Both the first and second sugars of the chain exhibit
well-defined electron density, assigned to two N-acetylglucos-
amine (GlcNAc) residues. Additional density is present for two
more sugars, which are modeled as mannose (Figure S1C). The
first GlcNAc forms several hydrogen bonds with nearby residues,
including the side chain of R1619 and the backbone carbonyl
oxygenofV1617. These two residuesare locatedat theC-terminal
end of helix 3 of the HD domain, and it is possible that these
hydrogen-bonding interactions between LNR-B and helix 3 help
in stabilizing the closed conformation of the protein. Interestingly,
bothNotch1andNotch2haveaconsensussugarmodificationsite
at the asparagine residue immediately preceding the first cysteine
of LNR-B, which is positioned at the N-terminal end of helix
3. Although the Notch2 protein used to solve the X-ray structureStructure 23, 1was prepared in bacteria, and is thus unglycosylated, the Notch1
NRR solved in complex with an inhibitory Fab (PDB: 3L95) was ex-
pressed in insect cells, and is glycosylated at this site (Wu et al.,
2010). The sugar residues that are modeled in the structure also
comewithin hydrogen-bonding distance of helix 3, andmay serve
to increase the stability of the ‘‘off’’ state of these proteins as well.
The other main site of structural divergence among the three
NRRs lies at the convergence point of the LNR-B and LNR-C
modules with the HD domain (Figure S1D). In the Notch3 NRR,
the connector between strand b4 and helix a3 containing the
disulfide knuckle of the HD domain is not helical as in Notch1
and Notch2, but is instead an extended loop that projects farther
from the core of the protein. The structural diversity in this region
may also contribute to differential responsiveness of various
receptors to different canonical ligands.
Structural Basis for Increased Basal Activity of Notch3
Our Notch3 NRR structure has two molecules in the asymmetric
unit (ASU), with an RMSD of less than 1 A˚ between the two
copies (Figure 2A). The most striking difference between the
two copies resides in the LNR-A domain, which is partially
disordered in one molecule (named mol-B), but is well defined
in the other (namedmol-A). The position of LNR-A is constrained
by packing interactions with a symmetry-related molecule in
mol-A but not in mol-B, suggesting that LNR-A is more dynamic
in the Notch3 NRR than anticipated. We revisited the question of
LNR-A positional flexibility for the other Notch NRRs by calcu-
lating normalized B-factor values for the LNR-A domain relative
to the rest of the structure for each Notch NRR in the PDB (Table
S1). Although the absolute value of the B factor is affected by
multiple influences including the quality of the data set, the
resolution, and crystal-packing interactions, the normalized
B-factor ratio for the LNR-A domain of the Notch3 NRR is
substantially higher than in other NRR structures (Table S1),
consistent with the idea that the LNR-A module of Notch3 is
more dynamic than its counterparts in Notch1 and Notch2.
We tested whether Notch3 exhibits a higher level of basal
(ligand-independent) signaling activity than either Notch1 or
Notch2 in U2OS cells using a reporter gene assay. These exper-
iments were performed using isogenic stable cell lines with
chimeric receptors (Gordon et al., 2009) that contain an intracel-
lular Gal4-responsive element to eliminate potential confounding
effects from endogenous receptors or differences in expression
levels (Figure S2A, bottom schematic). We examined the respon-
siveness of the different receptors to the DLL1 ligand immobi-
lized on the surface of the culture dish or on OP9 cells (Figures
2B and 2C), as well as to the Jag2 ligand expressed on NIH3T3-
cells (Figure S2B). In assays performed without ligand-express-
ing cells, with control cells that do not express the ligand, or with
immobilized immunoglobulin G (IgG) in place of DLL1, the basal
reporter activity of the Notch3-expressing cells is substantially
higher than that seen in Notch1- or Notch2-expressing cells,
even though the strength of the signal in the presence of either
DLL1 or Jag2 is comparable for all three receptors (Figures 2B
and 2C; Figure S2B). The amount of the mature Notch3 protein
is comparable with that of Notch1 and less than that of Notch2
in the compared isogenic lines, and thus the increased basal ac-
tivity of Notch3 cannot be attributed to an increased abundance
of the protein (Figure S2C). Together, the increased level of227–1235, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1229
Figure 2. Notch3 Shows Elevated Basal
Activity
(A) Superposition of the two copies of the Notch3
NRR in the asymmetric unit of the crystal. The
copy labeled Mol-B shows disorder in the LNR-A
module, shown in the close-up view (boxed).
(B and C) Notch3 shows higher amounts of re-
porter gene activity in the absence of ligand than
either Notch1 or Notch2. Isogenic stable cell lines
expressing Notch1, Notch2, or Notch3 chimeric
receptors that report on a Gal4-response element
(Malecki et al., 2006) were cultured either on plates
coated with IgG control, or the DLL1 ligand (B), or
in co-culture assays with OP9 stromal cells alone
or stably expressing DLL1 (C). The firefly luciferase
activity, normalized to a renilla luciferase control
(see Experimental Procedures) was measured in
cell lysates after 24 hr. In both (B) and (C), assays
were also performed in the presence of the
gamma-secretase inhibitor compound E (GSI) as a
control. Luciferase activity is normalized to the
Notch1 signal with IgG control (B), or with OP9
control cells (C). Error bars represent the SE of
three replicates. Using a one-way ANOVA, statis-
tically significant differences are indicated with
asterisks: ***p < 103; ****p < 104.
(D) Urea dissociation assay. Conditioned media
from 293T cells expressing either the Notch1 or
Notch3 NRR were immunoprecipitated with anti-
HA (a-HA)-coupled beads, followed by 30 min of
incubation at room temperature in buffer with
different concentrations of urea (0–4 M). Subunit
dissociation was evaluated by SDS-PAGE fol-
lowed by western blot analysis with anti-FLAG and
anti-HA antibodies, which are specific for the
N- and C-terminal subunits, respectively. See also
Figure S2.ligand-independent Notch3 proteolysis and the increased posi-
tional disorder of the LNR-A domain in the Notch3 NRR crystal
suggest that the autoinhibited conformation is more dynamic
and/or less stable in Notch3 than in Notch1 or Notch2.
To determine experimentally whether the Notch3 NRR was
less stable than the Notch1 NRR, we performed a subunit disso-
ciation assay in which the integrity of the furin-processed NRR
heterodimer wasmonitored as a function of added urea (Malecki
et al., 2006). Whereas the subunits of the Notch1 NRR hetero-
dimer remain non-covalently associated at concentrations up
to 4 M urea as reported previously (Malecki et al., 2006), the
Notch3 NRR is substantially more sensitive to urea-induced
dissociation, indicating that the Notch3 NRR is less stable than
the Notch1 NRR (Figure 2D).
Analysis of Disease-Associated Mutations Mapping to
the Notch3 NRR
Mutations of Notch3 are responsible for the hereditary stroke
syndrome known as CADASIL. Although the vast majority of
the CADASIL mutations lie in the epidermal growth factor1230 Structure 23, 1227–1235, July 7, 2015 ª2015 Elsevier Ltd All rights reserved(EGF)-like repeats, there is one CADASIL
mutation in the Notch3 HD, L1515P
(Fouillade et al., 2008), which lies on the
central b strand of the HD domain (Fig-ure 3A). In addition, a L1519P mutation has been reported to
segregate withmultiple affected individuals in a pedigree with fa-
milial autosomal-dominant infantile myofibromatosis (Martignetti
et al., 2013), and an acquired S1580L mutation of Notch3 has
been identified in the T-cell acute lymphoblastic leukemia/lym-
phoma cell line TALL1, (Cancer Genome UK). L1519P is located
in the linker region between b1 and b2 of theHD (Figure 3A), while
S1580 is located in b-strand 4 of the hydrophobic core, with its
side-chain oxygen atom within hydrogen-bonding distance of
the backbone carbonyl oxygen atoms of L1519 and P1520.
To test the effects of these mutations on ligand-independent
and ligand-dependent signaling, we introduced each of
these three mutations in the context of the full-length Notch3
protein (Figure S2A, top schematic), and tested the expression
of a luciferase reporter gene under control of the Notch-
responsive TP1 promoter in transient transfection assays (Kur-
ooka et al., 1998). The reporter gene assays show that the
S1580L mutation results in a large increase in ligand-indepen-
dent signaling. The L1515P mutation, as previously reported,
also produces a large increase in ligand-independent signaling
Figure 3. Analysis of Notch3 Disease-
Associated Mutations
(A) Cartoon close-up highlighting disease-associ-
ated sites of mutations and their interactions with
nearby residues.
(B) Reporter gene assay examining the ligand-in-
dependent activity and Jag2-stimulated activity of
full-length wild-type Notch3, and the S1580L,
L1515P, and L1519P mutated forms of Notch3.
The firefly luciferase gene was under control of the
TP1 promoter (Kurooka et al., 1998) and the Jag2
protein was expressed in stably transfected 3T3
cells (Luo et al., 1997). The ratio of firefly to control
renilla luciferase activity is plotted both in the
absence and presence of the gamma-secretase
inhibitor compound E (GSI). Luciferase activity is
normalized to the signal observed with vector
alone co-cultured with 3T3 cells. Error bars
represent the SE of three replicates. Using a one-
way ANOVA, statistically significant differences
are indicated with asterisks: *p < 0.05; ****p < 104.(Fouillade et al., 2008), whereas L1519P results in a modest,
but statistically significant increase in ligand-independent
signaling (Figure 3B).
Dimerization of the Notch3 NRR
The Notch3 NRR crystal contains two copies of the protein in
the ASU. The interface in the crystallographic dimer is entirely
derived from surface residues on the LNR-C module (Figure 4A),
which bury 1,088 A˚2 of surface area at the interface. The dimer
interface present in the Notch3 NRR structure closely resem-
bles the packing interface seen in all Notch NRR structures
deposited in the PDB (Figures 4A and S3A), including two
different X-ray structures of the isolated Notch1 NRR, a struc-
ture of a Notch1 NRR-Fab complex, and the structure of the
isolated Notch2 NRR (PDB: 3ETO, 3I08, 3L95, and 2OO4,
respectively). Multiple sequence alignment shows that this sur-
face patch on LNR-C is highly conserved among all Notch
NRRs (Figure 4B). Two key residues in this interface of the
Notch3 NRR dimer are Y1474 and H1478, which form symmet-
ric sandwich-like p-p interactions (Figure 4A, right panels).
These reciprocal interactions are buttressed on each molecule
by Y1471. Other important residues at the interface include
R1483, D1485, and Q1486 from both molecules. Equilibrium
sedimentation studies show that the Notch3 NRR does not
conform to a single-species model, and is best fit by a mono-
mer-dimer equilibrium model with an estimated dimerization Kd
of 30 mM (Figure S3B).
To examine whether the LNR-C dimerization interface con-
tributes functionally to Notch3 signaling, we created four
mutated forms of the full-length Notch3 receptor designed to
disrupt the dimer interface, Y1474E, Y1474R, H1478E, and
H1478R, and tested the effect of these mutations on ligand-in-
dependent and ligand-dependent signaling in both plated
ligand and cell co-culture assays. Both mutations of H1478
lead to significant increases in ligand-independent reporter
gene activity compared with the unmutated receptor (Figures
5 and S4), suggesting that the residues at the dimerization
interface play a role in maintaining the quiescent state of the re-
ceptor. Importantly, cells expressing the mutated receptors
appear to reach the cell surface normally (Figure S4), andStructure 23, 1respond to ligand comparably with the wild-type receptor
(Figure 5).
DISCUSSION
Notch receptor quiescence is mediated by the NRR, which
encompasses both the maturation cleavage site processed by
a furin-like proprotein convertase and themetalloprotease cleav-
age site that undergoes the key activating cleavage in response
to ligand stimulation. The structural and functional studies of the
Notch3 NRR reported here deepen the understanding of the
architectural features shared among Notch NRRs that encode
receptor autoinhibition, and highlight differences among the
Notch1, Notch2, and Notch3 NRRs that distinguish their sensi-
tivity to receptor activation.
Several lines of evidence support the conclusion that autoinhi-
bition of the Notch3 NRR is less stringent than that of the NRR
regions of Notch1 or Notch2. First, in the X-ray structure of the
Notch3 NRR, the LNR-A domain has a higher average B factor
than the other domains of the protein (Table S1), and is more
disordered than the analogous domain from Notch1 or Notch2
in the other NRR structures. In addition, the purified Notch3
NRR undergoes subunit dissociation at a much lower urea con-
centration, indicating that the Notch3 NRR is less stable than the
Notch1 or Notch2 NRRs. Likewise, the reporter gene assay
testing ligand-independent and ligand-dependent signaling
shows that the basal, ligand-independent signal of Notch3 in
the reporter assay using the Gal4 fusions with identical intracel-
lular regions is significantly stronger than the basal signal from
Notch1 or Notch2, even though the ligand-dependent signal
from all three receptors is comparable in the reporter assay. It
remains unclear, however, why the basal activity of full-length
Notch3 receptors in transient transfection assays is not as
consistent, nor why gamma-secretase inhibition (e.g. Figure 3B)
does not consistently suppress basal activity of full-length
receptors. One possibility is that the use of the Gal4 reporter
system improves assay signal-to-noise ratio by eliminating the
confounding effects of endogenous receptor signaling. Another
possibility is that the Notch3 intracellular domain, which is not
part of the molecules used to examine basal activity (Figure 2),227–1235, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1231
Figure 4. A Conserved Dimerization
Interface Is Observed in Different NRR
Structures
(A) Comparison of dimerization interfaces seen in
the Notch3 NRR, the Notch1 NRR (PDB: 3ETO),
and the Notch2 NRR (PDB: 2OO4). The left panels
illustrate the mode of interaction between the two
molecules, and the right panels, which represent
the boxed regions, highlight conserved features
among the three interfaces.
(B) Multiple sequence alignment showing conser-
vation of the residues at the interface (left), and a
surface representation of the Notch3 NRR struc-
ture (right) colored on a sliding scale from maroon
to teal blue according the extent of sequence
conservation using the program ConSurf (Ashke-
nazy et al., 2010). See also Figure S3.may contribute to restraint of basal signaling in the full-length
protein, compensating in part for the reduced stability of the
Notch3 NRR.
Increased basal Notch3 signaling activity might have partic-
ular relevance in pathogenic conditions where an increased
amount of Notch3 is expressed. For example, NOTCH3 lies
within a locus that is amplified in high-grade ovarian serous
adenocarcinomas (Cancer Genome Atlas Research Network,
2011; Park et al., 2006), and Notch3 has also been implicated1232 Structure 23, 1227–1235, July 7, 2015 ª2015 Elsevier Ltd All rights reservedin the pathogenesis of certain lung can-
cers (Konishi et al., 2007).
Both loss-of-function and gain-of-
function mutations of Notch3 receptors
are also associated with human devel-
opmental disorders and cancer (Aster
et al., 2011; Gridley, 2003; Joutel et al.,
1996). The three mutations known to
map to the HD of the Notch3 NRR
include the CADASIL mutation L1515P,
an infantile myofibromatosis mutation
L1519P, and the S1580L mutation found
in the TALL1 leukemia cell line. All
three mutations tested here are associ-
ated with ligand-independent gain of
function, suggesting that inhibitory anti-
bodies capable of blocking ligand-inde-
pendent signaling by binding the NRR
might have therapeutic utility in these
diseases.
Finally, the presence of a conserved
dimerization interface among Notch1,
Notch2, and Notch3, combined with
the analytical ultracentrifugation data
that fit best to a monomer-dimer equilib-
rium model, suggest that it possesses
functional importance. The restricted
distribution of molecules at the plasma
membrane, the observation of receptor
clustering in signaling complexes (Ahi-
mou et al., 2004; Bardot et al., 2005;
Nichols et al., 2007), and the presenceof an additional weak dimerization interface within the intracel-
lular ankyrin repeat domain of Notch (Allgood and Barrick,
2011; Nam et al., 2006, 2007) also point toward a potential
role for dimerization in modulating signal transduction. Consis-
tent with this idea, reporter gene assays suggest that autoinhi-
bition is partially disrupted by mutations that destabilize the
dimerization interface. However, a more detailed understand-
ing of the role of cell-surface Notch dimers will require future
study.
Figure 5. Effect of Mutations of Conserved Residues in the Dimer
Interface upon Signaling
(A) Reporter assay using plated ligand.Wild-type ormutated Notch3 receptors
were cultured either on plates coated with IgG control or the DLL1 ligand, and
treated with either DMSO carrier or a gamma-secretase inhibitor.
(B) Reporter assay using co-cultured cells expressing the DLL1 ligand. Wild-
type or mutated Notch3 receptors were co-cultured either with OP9 stromal
cells alone or with OP9 cells stably expressing the DLL1 ligand, and treated
with either DMSO carrier or a gamma-secretase inhibitor. In both (A) and (B),
firefly luciferase activity, normalized to a renilla luciferase control, was
measured in cell lysates after 24 hr. Luciferase activity is normalized to the
signal observed for cells transfected with full-length Notch3 cultured on the
plated IgG control (A), or with OP9 cells alone (B). Error bars represent the SE of
three replicates. Using a one-way ANOVA, statistically significant differences
are indicated with asterisks: *p < 0.05; **p < 0.01. See also Figure S4.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
For crystallization, the Notch3 NRR was subcloned into a modified pcDNA-
series plasmid encoding the IgG kappa signal sequence, followed by the
Notch3 NRR (1,378–1,640), and an in-frame gly-ser-his6 tag at the C termi-
nus. The encoded protein was expressed and secreted into the conditioned
media by HEK293S GnTi cells (Reeves et al., 2002). The medium was
collected after 4 days, and the NRR was bound to Ni-NTA beads (Qiagen)
over a 3-hr incubation period at 4C. After a wash with 50 mM HEPES buffer
containing 500 mM NaCl and 20 mM imidazole, bound protein was eluted in
50 mM HEPES buffer containing 500 mM NaCl and 250 mM imidazole. After
buffer exchange into 50 mM Tris (pH 8.0) containing 50 mM NaCl and 10 mM
CaCl2, the Notch3 NRR protein was passed over a Hi-trap Q HP column and
eluted using an NaCl gradient. The recovered Notch3 NRR was incompletely
processed into two subunits by furin, as judged by SDS-PAGE. Thus, the
protein was treated with furin (30 U/mg) at room temperature for 6 hr, and
the fully processed protein was further purified by size-exclusion chroma-
tography on a Superdex 75 HR 10/30 column after buffer exchange into
20 mM HEPES buffer (pH 7.4) containing 150 mM NaCl and 10 mM
CaCl2. The protein was concentrated to 45 mg/ml for initial crystallization
screening.Structure 23, 1Crystallization, Data Collection, and Structural Refinement
Crystallization trials were carried out using the sitting drop vapor-diffusion
method at both 22C and 4C. Initial crystals were obtained in two conditions:
one at 4C containing 0.2 M ammonium sulfate, 15% PEG4000, and 0.1 M
trisodium citrate (pH 5.6), and the other at 22C containing 20% isopropanol,
20% PEG4000, and 0.1 M trisodium citrate (pH 5.6). After iterative refinement,
final crystals were grown at 22C by mixing equal volumes of Notch3 NRR at
5 mg/ml with a precipitant solution containing 0.2 M sodium acetate, 20%
PEG4000, and 0.1 M trisodium citrate at pH 5.4. Plate-like crystals typically
grew within 2 weeks reaching a maximal size of 0.05 3 0.5 3 0.5 mm3. For
data collection, a single crystal was flash-frozen from a precipitant solution
containing 20% (v/v) glycerol.
Diffraction data were collected from a flash-cooled crystal at 100 K using the
24ID-E beamline at Argonne National Laboratory and were processed, inte-
grated, and scaled together with HKL2000 (Otwinowski and Minor, 1997).
The criterion used for data inclusion was based on the value of CC1/2 (Karplus
and Diederichs, 2012). The Notch3 NRR structure was solved by molecular
replacement as implemented in Phenix (Adams et al., 2010) using a Notch1
NRR structure (PDB: 3ETO) as the search model. Structure refinement was
carried out using conjugate-gradient energyminimization, torsion-constrained
molecular dynamics-simulated annealing, group B-factor refinement, individ-
ual B-factor refinement, and TLS (Translation/Libration/Screw) protocols in
Phenix with 5%of the reflections omitted for free R-factor calculation. Electron
density peaks in difference Fourier maps at a height of above 3swere assigned
as water molecules in later refinement stages if they had reasonable geometry
in relation to hydrogen bond donors or acceptors and their B factors did not
rise above 50 A˚2 during subsequent refinement.Model building was performed
in Coot (Emsley and Cowtan, 2004) guided by sA-weighted 2Fo  Fc maps,
Fo  Fc maps, and composite omit maps. All structure figures were generated
using PyMOL v1.7 (Schrodinger, 2010).
Luciferase Reporter Assay
Luciferase reporter gene assays were carried out using methods previously
described (Gordon et al., 2009). For the studies in Figures 2 and S2B,
experiments were performed using isogenic stable cell lines with chimeric
Notch1-, Notch2-, or Notch3-Gal4 fusions, and the reporter was a Gal4-
responsive element. For studies testing disease-associated or dimer interface
mutations, the full-length Notch3 protein was used in transient transfections of
U2OS cells, and the reporter was the TP1 Notch-responsive element. In plated
ligand assays, the various Notch-expressing cells were cultured on tissue
culture plates treated with either soluble DLL1 ligand (spanning from the N
terminus through EGF-like repeat 5 [Andrawes et al., 2013]) or an IgG control
protein in the absence or presence of a gamma-secretase inhibitor, compound
E (1 mM). In the co-culture assays, OP9 cells alone or stably expressing DLL1,
or 3T3 cells alone or stably expressing Jag2, were used as signal-sending
cells, again in the absence or presence of a gamma-secretase inhibitor,
compound E (1 mM).
Urea Dissociation Assay
Urea dissociation assays were performed essentially as described previously
(Malecki et al., 2006). The Notch1 (Malecki et al., 2006) or Notch3 NRR (S1382-
S1640, flanked by N-terminal FLAG and C-terminal hemagglutinin [HA] tags)
was recovered from conditioned media using anti-HA antibody-conjugated
beads in 50 mM Tris buffer (pH 7.5) containing 150 mM NaCl and 0.1%
NP40, and subjected to varying concentrations of urea for a period of
30 min before recovery of the beads by centrifugation. After three rapid
washes in the incubation buffer, the proteins retained on the beads were
analyzed by western blotting.
Analytical Ultracentrifugation
Analytical ultracentrifugation was performed in six-sectored cells using a
Beckman Coulter Optima XL-A analytical ultracentrifuge equipped with an
An-60 Ti analytical rotor. Before centrifugation, wild-type Notch3 NRR protein
was extensively dialyzed into 25mMHEPES buffer (pH 7.5) containing 150mM
NaCl and 5mMCaCl2. Protein concentrations of 3, 9, and 27 mMwere prepared
by dilution of a stock solution with the dialysate, and the dialysate was used in
the three reference channels. Samples were centrifuged at 14,000 and
18,000 rpm at 4C until equilibrium was reached, as judged by the stability227–1235, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1233
of absorption scans taken at wavelengths of 230, 280, and 290 nm over two
consecutive 2-hr intervals. Data for final analysis were acquired by averaging
ten scans at each wavelength using 1-nm steps, and only data in the linear
range of the instrument (between 0.01 and 1 absorbance unit) were used for
subsequent analysis. Global fitting was carried out using the Origin 6.0 soft-
ware package comparing fits to distinguish between a single-species model
and amonomer-dimer equilibrium, and to estimate a value for the dimerization
Kd. Plots comparing fits to a monomer-dimer equilibrium with a 30-mMvalue of
Kd (left panel) or a single-species monomer (right panel) are shown for 280-nm
scan of the 9-mM sample spun at 18,000 rpm in Figure S3B.
Immunofluorescence and Flow Cytometry
Detection of various Notch proteins on the surface of U2OS cells was carried
out using a mouse IgG anti-Notch3 antibody A13 (Li et al., 2008), followed by
secondary detection with goat anti-mouse IgG coupled to Alexa546. Flow
cytometry was carried out using the same antibodies, using a BD Accuri C6
instrument. The data were analyzed using BD Accuri C6 software.
ACCESSION NUMBERS
Coordinates of the Notch3 NRR have been deposited in the PDB (PDB: 4ZLP).
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